drugset / Trial / NCT01814319

Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure

NCT01814319

Phase 2 Completed 20 enrolled University of Cincinnati
RandomizedCrossoverTriple-blindTreatment

Summary

Probenecid is an FDA approved drug for the treatment gout and hyperuricemia. It has been used safely in humans for decades for this and other indications. The investigators have recently discovered that this drug can also stimulate other receptors in the heart and therefore improve its function. The hypothesis of this study is that probenecid can be used to improve the function of the heart and therefore the symptoms in patients with heart failure.

Timeline

Start
2013-03
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Probenecid Small molecule 1 g Oral